Laura Kate Gadanec

Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2

Harry Ridgway, Graham J. Moore, Thomas Mavromoustakos et al. · Computational and Structural Biotechnology Journal · 2022 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy

Harry Ridgway, Christos T. Chasapis, Konstantinos Kelaidonis et al. · Viruses · 2022 · 36 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19

Graham J. Moore, José Maria Pires, Konstantinos Kelaidonis et al. · Biomolecules · 2021 · 23 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

The Effect of Recombinant Undercarboxylated Osteocalcin on Endothelial Dysfunction

Tawar Qaradakhi, Laura Kate Gadanec, Alexander Tacey et al. · Calcified Tissue International · 2019 · 20 citations

Medicine, Pharmacology, Bone Metabolism +12

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies

Harry Ridgway, Graham J. Moore, Laura Kate Gadanec et al. · Expert Opinion on Therapeutic Targets · 2024 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +16